CD146/sCD146 in the Pathogenesis and Monitoring of Angiogenic and Inflammatory Diseases

被引:21
|
作者
Heim, Xavier [1 ,2 ]
Joshkon, Ahmad [1 ]
Bermudez, Julien [1 ,3 ]
Bachelier, Richard [1 ]
Dubrou, Clea [1 ]
Boucraut, Jose [2 ,4 ]
Foucault-Bertaud, Alexandrine [1 ]
Leroyer, Aurelie S. [1 ]
Dignat-George, Francoise [1 ,5 ]
Blot-Chabaud, Marcel [1 ]
Bardin, Nathalie [1 ,2 ]
机构
[1] Aix Marseille Univ, Inst Natl Sante & Rech Med INSERM, Inst Natl Rech Agr Alimentat & Environm INRAE, Hematol Dept,Ctr CardioVasc & Nutr Res C2VN,Fac P, Timone Campus, F-13005 Marseille, France
[2] Hop Conception, AP HM, Pole Biol, Serv Immunol, F-13005 Marseille, France
[3] North Hosp, AP HM, Dept Pulmonol, F-13015 Marseille, France
[4] North Hosp, AP HM, Lung Transplant Team, F-13015 Marseille, France
[5] Aix Marseille Univ, Timone Neurosci Inst, UMR CNRS 7289, F-13005 Marseille, France
关键词
CD146; soluble CD146; inflammation angiogenesis; autoimmunity; ENDOTHELIAL PROGENITOR CELLS; CD4(+) T-CELLS; SOLUBLE CD146; ADHESION MOLECULES; INCREASED EXPRESSION; SYSTEMIC-SCLEROSIS; MARKER; MELANOMA; MCAM; MUC18;
D O I
10.3390/biomedicines8120592
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CD146 is a cell adhesion molecule expressed on endothelial cells, as well as on other cells such as mesenchymal stem cells and Th17 lymphocytes. This protein also exists in a soluble form, whereby it can be detected in biological fluids, including the serum or the cerebrospinal fluid (CSF). Some studies have highlighted the significance of CD146 and its soluble form in angiogenesis and inflammation, having been shown to contribute to the pathogenesis of many inflammatory autoimmune diseases, such as systemic sclerosis, mellitus diabetes, rheumatoid arthritis, inflammatory bowel diseases, and multiple sclerosis. In this review, we will focus on how CD146 and sCD146 contribute to the pathogenesis of the aforementioned autoimmune diseases and discuss the relevance of considering it as a biomarker in these pathologies.
引用
收藏
页码:1 / 13
页数:13
相关论文
共 50 条
  • [31] CD146 is a Potential Therapeutic Target for Neuroblastoma
    Obu, Satoshi
    Umeda, Katsutsugu
    Sonoda, Mari
    Kato, Itaru
    Hiramatsu, Hidefumi
    Ogawa, Eri
    Okamoto, Shinya
    Okajima, Hideaki
    Morita, Ken
    Kamikubo, Yasuhiko
    Kawaguchi, Kouji
    Watanabe, Kenichiro
    Yagyu, Shigeki
    Iehara, Tomoko
    Hosoi, Hajime
    Nakahata, Tatsutoshi
    Adachi, Souichi
    Uemoto, Shinji
    Takita, Junko
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S83 - S84
  • [32] PTEN and CD146 expression in endometrioid adenocarcinoma
    Huang, Q.
    He, Y.
    Cao, X.
    Yi, C.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2020, 41 (03) : 439 - 443
  • [33] Soluble Melanoma Cell Adhesion Molecule (sMCAM/sCD146) Promotes Angiogenic Effects on Endothelial Progenitor Cells through Angiomotin
    Stalin, Jimmy
    Harhouri, Karim
    Hubert, Lucas
    Subrini, Caroline
    Lafitte, Daniel
    Lissitzky, Jean-Claude
    Elganfoud, Nadia
    Robert, Stephane
    Foucault-Bertaud, Alexandrine
    Kaspi, Elise
    Sabatier, Florence
    Aurrand-Lions, Michel
    Bardin, Nathalie
    Holmgren, Lars
    Dignat-George, Francoise
    Blot-Chabaud, Marcel
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (13) : 8991 - 9000
  • [34] Plasma sCD146 is a potential biomarker for acute exacerbation of chronic obstructive pulmonary disease
    Jia, Xinyu
    Jiang, Jingxian
    Yang, Chen
    Zhang, Sujuan
    Wu, Jingjing
    Ma, Qiyun
    Wang, Zhengxia
    Chen, Zhongqi
    Zhang, Mingshun
    Huang, Mao
    Ji, Ningfei
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (03):
  • [35] Endothelial cell adhesion molecule CD146: implications for its role in the pathogenesis of COPD
    Kratzer, Adelheid
    Chu, Hong Wei
    Salys, Jonas
    Moumen, Zakaria
    Leberl, Maike
    Bowler, Russ
    Cool, Carlyne
    Zamora, Martin
    Taraseviciene-Stewart, Laima
    JOURNAL OF PATHOLOGY, 2013, 230 (04): : 388 - 398
  • [36] Soluble CD146, a biomarker and a target for preventing resistance to anti-angiogenic therapy in glioblastoma
    Ahmad Joshkon
    Emeline Tabouret
    Wael Traboulsi
    Richard Bachelier
    Stéphanie Simoncini
    Sandrine Roffino
    Carine Jiguet-Jiglaire
    Bassam Badran
    Benjamin Guillet
    Alexandrine Foucault-Bertaud
    Aurelie S. Leroyer
    Françoise Dignat-George
    Olivier Chinot
    Hussein Fayyad-Kazan
    Nathalie Bardin
    Marcel Blot-Chabaud
    Acta Neuropathologica Communications, 10
  • [37] Soluble CD146, a biomarker and a target for preventing resistance to anti-angiogenic therapy in glioblastoma
    Joshkon, Ahmad
    Tabouret, Emeline
    Traboulsi, Wael
    Bachelier, Richard
    Simoncini, Stephanie
    Roffino, Sandrine
    Jiguet-Jiglaire, Carine
    Badran, Bassam
    Guillet, Benjamin
    Foucault-Bertaud, Alexandrine
    Leroyer, Aurelie S.
    Dignat-George, Francoise
    Chinot, Olivier
    Fayyad-Kazan, Hussein
    Bardin, Nathalie
    Blot-Chabaud, Marcel
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2022, 10 (01)
  • [38] Soluble CD146 is generated by ectodomain shedding of membrane CD146 in a calcium-induced, matrix metalloprotease-dependent process
    Boneberg, Eva-Maria
    Illges, Harald
    Legler, Daniel F.
    Fuerstenberger, Gregor
    MICROVASCULAR RESEARCH, 2009, 78 (03) : 325 - 331
  • [39] Differential expression of drug resistance genes in CD146 positive dental pulp derived stem cells and CD146 negative fibroblasts
    Tavangar, Maryam S.
    Attar, Armin
    Razmkhah, Mahboobeh
    Hosseini, Seyed-Mojtaba
    Hosseini, Ahmad
    Monabati, Ahmad
    Shafiei, Fereshteh
    CLINICAL AND EXPERIMENTAL DENTAL RESEARCH, 2020, 6 (04): : 448 - 456
  • [40] sCD146 antigen serum levels in patients after allogeneic stem cell transplantation
    Kusnierz-Cabala, B
    Hawrylecka, D
    Naskalski, J
    Mensah-Glanowska, P
    Piatkowska-Jakubas, B
    Skotnicki, AB
    BONE MARROW TRANSPLANTATION, 2006, 37 : S125 - S126